Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Biosimilars market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Mylan N.V
F. Hoffmann-La Roche AG
Dr. Reddy’s Laboratories Ltd.
Amgen Inc.
Sandoz International GmbH
Pfizer Inc
Dr Reddy’s Laboratories Ltd.
Mylan NV
F Hoffmann-La Roche AG
By Type:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
By End-User:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars Market
-
1.3 Market Segment by Type
1.3.1 Japan Biosimilars Market Size and Growth Rate of Human growth hormone from 2014 to 2026
1.3.2 Japan Biosimilars Market Size and Growth Rate of Erythropoietin from 2014 to 2026
1.3.3 Japan Biosimilars Market Size and Growth Rate of Monoclonal antibodies from 2014 to 2026
1.3.4 Japan Biosimilars Market Size and Growth Rate of Insulin from 2014 to 2026
1.3.5 Japan Biosimilars Market Size and Growth Rate of Interferon from 2014 to 2026
1.3.6 Japan Biosimilars Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2014 to 2026
1.3.7 Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Biosimilars Market Size and Growth Rate of Oncology from 2014 to 2026
1.4.2 Japan Biosimilars Market Size and Growth Rate of Blood Disorders from 2014 to 2026
1.4.3 Japan Biosimilars Market Size and Growth Rate of Growth Hormonal Deficiency from 2014 to 2026
1.4.4 Japan Biosimilars Market Size and Growth Rate of Chronic and Autoimmune Disorders from 2014 to 2026
1.4.5 Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilars by Major Types
3.4.1 Market Size and Growth Rate of Human growth hormone
3.4.2 Market Size and Growth Rate of Erythropoietin
3.4.3 Market Size and Growth Rate of Monoclonal antibodies
3.4.4 Market Size and Growth Rate of Insulin
3.4.5 Market Size and Growth Rate of Interferon
3.4.6 Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor
3.4.7 Market Size and Growth Rate of Others
4 Segmentation of Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilars by Major End-Users
4.4.1 Market Size and Growth Rate of Biosimilars in Oncology
4.4.2 Market Size and Growth Rate of Biosimilars in Blood Disorders
4.4.3 Market Size and Growth Rate of Biosimilars in Growth Hormonal Deficiency
4.4.4 Market Size and Growth Rate of Biosimilars in Chronic and Autoimmune Disorders
4.4.5 Market Size and Growth Rate of Biosimilars in Others
5 Market Analysis by Regions
-
5.1 Japan Biosimilars Production Analysis by Regions
-
5.2 Japan Biosimilars Consumption Analysis by Regions
6 Hokkaido Biosimilars Landscape Analysis
-
6.1 Hokkaido Biosimilars Landscape Analysis by Major Types
-
6.2 Hokkaido Biosimilars Landscape Analysis by Major End-Users
7 Tohoku Biosimilars Landscape Analysis
-
7.1 Tohoku Biosimilars Landscape Analysis by Major Types
-
7.2 Tohoku Biosimilars Landscape Analysis by Major End-Users
8 Kanto Biosimilars Landscape Analysis
-
8.1 Kanto Biosimilars Landscape Analysis by Major Types
-
8.2 Kanto Biosimilars Landscape Analysis by Major End-Users
9 Chubu Biosimilars Landscape Analysis
-
9.1 Chubu Biosimilars Landscape Analysis by Major Types
-
9.2 Chubu Biosimilars Landscape Analysis by Major End-Users
10 Kinki Biosimilars Landscape Analysis
-
10.1 Kinki Biosimilars Landscape Analysis by Major Types
-
10.2 Kinki Biosimilars Landscape Analysis by Major End-Users
11 Chugoku Biosimilars Landscape Analysis
-
11.1 Chugoku Biosimilars Landscape Analysis by Major Types
-
11.2 Chugoku Biosimilars Landscape Analysis by Major End-Users
12 Shikoku Biosimilars Landscape Analysis
-
12.1 Shikoku Biosimilars Landscape Analysis by Major Types
-
12.2 Shikoku Biosimilars Landscape Analysis by Major End-Users
13 Kyushu Biosimilars Landscape Analysis
-
13.1 Kyushu Biosimilars Landscape Analysis by Major Types
-
13.2 Kyushu Biosimilars Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Mylan N.V
14.1.1 Mylan N.V Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 F. Hoffmann-La Roche AG
14.2.1 F. Hoffmann-La Roche AG Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Dr. Reddy’s Laboratories Ltd.
14.3.1 Dr. Reddy’s Laboratories Ltd. Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Amgen Inc.
14.4.1 Amgen Inc. Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Sandoz International GmbH
14.5.1 Sandoz International GmbH Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Pfizer Inc
14.6.1 Pfizer Inc Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Dr Reddy’s Laboratories Ltd.
14.7.1 Dr Reddy’s Laboratories Ltd. Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Mylan NV
14.8.1 Mylan NV Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 F Hoffmann-La Roche AG
14.9.1 F Hoffmann-La Roche AG Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
The List of Tables and Figures (Totals 110 Figures and 120 Tables)
Figure Japan Biosimilars Market Size and Growth Rate of Human growth hormone from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Erythropoietin from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Monoclonal antibodies from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Insulin from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Interferon from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Biosimilars Market Size and Growth Rate of Oncology from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Blood Disorders from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Growth Hormonal Deficiency from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Chronic and Autoimmune Disorders from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Biosimilars
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilars by Different Types from 2014 to 2026
-
Table Consumption Share of Biosimilars by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Human growth hormone
Figure Market Size and Growth Rate of Erythropoietin
Figure Market Size and Growth Rate of Monoclonal antibodies
Figure Market Size and Growth Rate of Insulin
Figure Market Size and Growth Rate of Interferon
Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Biosimilars by Different End-Users from 2014 to 2026
-
Table Consumption Share of Biosimilars by Different End-Users from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Oncology from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Blood Disorders from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Growth Hormonal Deficiency from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Chronic and Autoimmune Disorders from 2014 to 2026
Figure Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan Biosimilars Production by Regions
-
Table Japan Biosimilars Production Share by Regions
-
Figure Japan Biosimilars Production Share by Regions in 2014
-
Figure Japan Biosimilars Production Share by Regions in 2018
-
Figure Japan Biosimilars Production Share by Regions in 2026
-
Table Japan Biosimilars Consumption by Regions
-
Table Japan Biosimilars Consumption Share by Regions
-
Figure Japan Biosimilars Consumption Share by Regions in 2014
-
Figure Japan Biosimilars Consumption Share by Regions in 2018
-
Figure Japan Biosimilars Consumption Share by Regions in 2026
-
Table Hokkaido Biosimilars Consumption by Types from 2014 to 2026
-
Table Hokkaido Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Biosimilars Consumption Share by Types in 2014
-
Figure Hokkaido Biosimilars Consumption Share by Types in 2018
-
Figure Hokkaido Biosimilars Consumption Share by Types in 2026
-
Table Hokkaido Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Biosimilars Consumption Share by End-Users in 2014
-
Figure Hokkaido Biosimilars Consumption Share by End-Users in 2018
-
Figure Hokkaido Biosimilars Consumption Share by End-Users in 2026
-
Table Tohoku Biosimilars Consumption by Types from 2014 to 2026
-
Table Tohoku Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Biosimilars Consumption Share by Types in 2014
-
Figure Tohoku Biosimilars Consumption Share by Types in 2018
-
Figure Tohoku Biosimilars Consumption Share by Types in 2026
-
Table Tohoku Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Tohoku Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Biosimilars Consumption Share by End-Users in 2014
-
Figure Tohoku Biosimilars Consumption Share by End-Users in 2018
-
Figure Tohoku Biosimilars Consumption Share by End-Users in 2026
-
Table Kanto Biosimilars Consumption by Types from 2014 to 2026
-
Table Kanto Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kanto Biosimilars Consumption Share by Types in 2014
-
Figure Kanto Biosimilars Consumption Share by Types in 2018
-
Figure Kanto Biosimilars Consumption Share by Types in 2026
-
Table Kanto Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kanto Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Biosimilars Consumption Share by End-Users in 2014
-
Figure Kanto Biosimilars Consumption Share by End-Users in 2018
-
Figure Kanto Biosimilars Consumption Share by End-Users in 2026
-
Table Chubu Biosimilars Consumption by Types from 2014 to 2026
-
Table Chubu Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chubu Biosimilars Consumption Share by Types in 2014
-
Figure Chubu Biosimilars Consumption Share by Types in 2018
-
Figure Chubu Biosimilars Consumption Share by Types in 2026
-
Table Chubu Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chubu Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Biosimilars Consumption Share by End-Users in 2014
-
Figure Chubu Biosimilars Consumption Share by End-Users in 2018
-
Figure Chubu Biosimilars Consumption Share by End-Users in 2026
-
Table Kinki Biosimilars Consumption by Types from 2014 to 2026
-
Table Kinki Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kinki Biosimilars Consumption Share by Types in 2014
-
Figure Kinki Biosimilars Consumption Share by Types in 2018
-
Figure Kinki Biosimilars Consumption Share by Types in 2026
-
Table Kinki Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kinki Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Biosimilars Consumption Share by End-Users in 2014
-
Figure Kinki Biosimilars Consumption Share by End-Users in 2018
-
Figure Kinki Biosimilars Consumption Share by End-Users in 2026
-
Table Chugoku Biosimilars Consumption by Types from 2014 to 2026
-
Table Chugoku Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Biosimilars Consumption Share by Types in 2014
-
Figure Chugoku Biosimilars Consumption Share by Types in 2018
-
Figure Chugoku Biosimilars Consumption Share by Types in 2026
-
Table Chugoku Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chugoku Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Biosimilars Consumption Share by End-Users in 2014
-
Figure Chugoku Biosimilars Consumption Share by End-Users in 2018
-
Figure Chugoku Biosimilars Consumption Share by End-Users in 2026
-
Table Shikoku Biosimilars Consumption by Types from 2014 to 2026
-
Table Shikoku Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Biosimilars Consumption Share by Types in 2014
-
Figure Shikoku Biosimilars Consumption Share by Types in 2018
-
Figure Shikoku Biosimilars Consumption Share by Types in 2026
-
Table Shikoku Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Shikoku Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Biosimilars Consumption Share by End-Users in 2014
-
Figure Shikoku Biosimilars Consumption Share by End-Users in 2018
-
Figure Shikoku Biosimilars Consumption Share by End-Users in 2026
-
Table Kyushu Biosimilars Consumption by Types from 2014 to 2026
-
Table Kyushu Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Biosimilars Consumption Share by Types in 2014
-
Figure Kyushu Biosimilars Consumption Share by Types in 2018
-
Figure Kyushu Biosimilars Consumption Share by Types in 2026
-
Table Kyushu Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kyushu Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Biosimilars Consumption Share by End-Users in 2014
-
Figure Kyushu Biosimilars Consumption Share by End-Users in 2018
-
Figure Kyushu Biosimilars Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Mylan N.V
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan N.V
Figure Sales and Growth Rate Analysis of Mylan N.V
Figure Revenue and Market Share Analysis of Mylan N.V
Table Product and Service Introduction of Mylan N.V
Table Company Profile and Development Status of F. Hoffmann-La Roche AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche AG
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche AG
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche AG
Table Product and Service Introduction of F. Hoffmann-La Roche AG
Table Company Profile and Development Status of Dr. Reddy’s Laboratories Ltd.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy’s Laboratories Ltd.
Figure Sales and Growth Rate Analysis of Dr. Reddy’s Laboratories Ltd.
Figure Revenue and Market Share Analysis of Dr. Reddy’s Laboratories Ltd.
Table Product and Service Introduction of Dr. Reddy’s Laboratories Ltd.
Table Company Profile and Development Status of Amgen Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc.
Figure Sales and Growth Rate Analysis of Amgen Inc.
Figure Revenue and Market Share Analysis of Amgen Inc.
Table Product and Service Introduction of Amgen Inc.
Table Company Profile and Development Status of Sandoz International GmbH
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH
Figure Sales and Growth Rate Analysis of Sandoz International GmbH
Figure Revenue and Market Share Analysis of Sandoz International GmbH
Table Product and Service Introduction of Sandoz International GmbH
Table Company Profile and Development Status of Pfizer Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
Figure Sales and Growth Rate Analysis of Pfizer Inc
Figure Revenue and Market Share Analysis of Pfizer Inc
Table Product and Service Introduction of Pfizer Inc
Table Company Profile and Development Status of Dr Reddy’s Laboratories Ltd.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy’s Laboratories Ltd.
Figure Sales and Growth Rate Analysis of Dr Reddy’s Laboratories Ltd.
Figure Revenue and Market Share Analysis of Dr Reddy’s Laboratories Ltd.
Table Product and Service Introduction of Dr Reddy’s Laboratories Ltd.
Table Company Profile and Development Status of Mylan NV
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV
Figure Sales and Growth Rate Analysis of Mylan NV
Figure Revenue and Market Share Analysis of Mylan NV
Table Product and Service Introduction of Mylan NV
Table Company Profile and Development Status of F Hoffmann-La Roche AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG
Table Product and Service Introduction of F Hoffmann-La Roche AG
-
